Michigan researchers find safer cardiac ablation method; Life Technologies taking HIV Dx to Africa;

 @FierceMedDev: Siemens snagged FDA clearance for a new MRI scanner the company says is more cost-effective than its competitors. Release | Follow @FierceMedDev

 @MarkHFierce: A new study connects increased heart attack risk with total hip and knee replacement surgery. More | Follow @MarkHFierce

 @DamianFierce: The FDA has slapped CareFusion with another Class I recall over leaky ventilators. Story | Follow @DamianFierce

> Universal Hospital Services, which manages and services medical equipment for the healthcare industry, is proposing a $425 million private offering. Release

> Researchers at the University of Michigan report that cell-specific targeting with cardiac ablation devices could reduce the need for repeat procedures in patients with cardiac arrhythmia. Release

> The Health Information Trust Alliance is launching its Cyber Threat Analysis Service, compiling intelligence to protect medical records and devices from cyber attacks and hacking. News

> Life Technologies ($LIFE) is teaming up with the Southern African Treatment and Resistance Network to provide low-cost HIV diagnostics in that country. More

> Illumina ($ILMN) is launching NuPCR, a new real-time diagnostic reagent for customized multiplex assays. Item

> Ariosa Diagnostics completed its first clinical study for Harmony, a pre-natal test designed to detect common fetal trisomies. Ariosa is currently being sued by Sequenom, which claims Harmony violates its patent on a similar test. Story

> Codman Neurovascular, which is part of Johnson & Johnson ($JNJ), is launching two new microcoil systems in the United States and Europe. Release

> Oakworks, a designer and maker of medical positioning equipment, treatment tables and accessories, has named former Aramark executive Richard Shuman as its new chief financial officer. Release

Biotech News

 @FierceBiotech: A handful of genetic mutations drive acute leukemia transformation. Article | Follow @FierceBiotech

 @JohnCFierce: Washout. Via NYT: Bapi investigator says "absolutely no evidence at all of a clinical benefit". Report | Follow @JohnCFierce

 @RyanMFierce: Hard to find who in bio isn't using Big Data. Special Report: 10 Reasons Why Biotech Needs Big Data. Report | Follow @RyanMFierce

> Merck snags Chimerix antiviral HIV program in $168.5M deal. News

> Pfizer, J&J report ominous PhIII failure of bapineuzumab in Alzheimer's study. Article

> Forest outpaces major league rivals in race for a COPD drug approval. Story

> Sarepta extension study delivers promising results for DMD patients. Item

Pharma News

 @FiercePharma: Acorda's MS drug Ampyra gets FDA warning on seizure risks. More | Follow @FiercePharma

> Tang Capital can't shuttle Savient into receivership, judge says. Article

> Italian drug cuts threaten thousands of jobs, industry says. Story

> FDA staff backs Roche's Lucentis for new use. News

Pharma Manufacturing News

> Owens & Minor buys unit from wholesaler Celesio. More

> Strides Arcolab to expand manufacturing in Africa with French investment. Report

> Drugmakers played unintended role in counterfeits hitting U.S. Article

> New Florida drugmaker springs from debacle of another. Story

> NZ doc faces 30 years after fake Cialis conviction. News

Biotech Research News

> Novel class of Alzheimer's drugs looks promising in animals. Story

> A handful of genetic mutations drive acute leukemia transformation. Article

> One molecule may stand in the way of liver cancer. Report

> Genetic mutations linked to childhood brain cancer subtypes. More

And Finally... Analysts project the "sleep industry" could be worth $32.4 billion this year, including drugs, therapy and a burgeoning field of devices designed to help patients get a good night's rest. Article